2d COVID-19 vaccine wins backing from U.S. skilled panel, paving way for remaining FDA decision on emergency use.

WASHINGTON (AP) — A second COVID-19 vaccine wins backing from U.S. expert panel, paving means for remaining FDA determination on emergency use.

Pharmaceutical big Moderna received backing via the FDA panel for its COVID-19 vaccine.

This comes a week after Pfizer’s vaccine was authorised.

Moderna’s vaccine could come to Connecticut as early as subsequent week.